Imaging as marker of remission in SpA

Recent Posts

Ambrisentan reduces risk of pulmonary arterial hypertension in systemic sclerosis patients, study finds
Post-hoc analysis demonstrates the efficacy of tofacitinib in ankylosing spondylitis regardless of baseline C-reactive protein levels
Phase 2 trial of remibrutinib shows promising results for managing Sjögren’s syndrome
IFI44 identified as a novel biomarker for primary Sjögren’s syndrome
Phase 2b RISE-SSc trial reveals potential predictors of response to riociguat in early diffuse cutaneous systemic sclerosis

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. @2020 ChanRe Healthcare & Research Pvt Ltd.

Home
Student Corner
- PG Section
- UG Section
Case Discussion
Research
- Journal Club
Webinar
News and Views
Conference
Quiz
Rheuma Pics Hub

Search for:

Share this:

Similar Posts